SCHEMBL784590

SCHEMBL784590

CNC1CCN(c2ccc(F)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
LMNA P02545 2/20 0.53
ALDH1A1 P00352 2/20 0.53
MAPK1 P28482 2/20 0.53
HTT P42858 1/20 0.53
GFER P55789 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
CYP2D6 P10635 1/20 0.48
CHRM1 P11229 1/20 0.48
HRH1 P35367 1/20 0.48
NOTUM Q6P988 1/20 0.46
NPY5R Q15761 1/20 0.46
TP53 P04637 3/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
LIPG Q9Y5X9 1/20 0.43
RECQL P46063 1/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5250062 0.92 CYP2D6 (0.52) MAPTLMNAALDH1A1MAPK1HTT
SCHEMBL16423528 0.89 NOTUM (0.51) MAPTLMNAALDH1A1MAPK1HTT
SCHEMBL3440289 0.83 MAPT (0.55) MAPTLMNAALDH1A1MAPK1HTT
SCHEMBL8728954 0.83 ADRB1 (0.50) MAPTLMNAALDH1A1KDM4EMEN1
SCHEMBL785834 0.81 KMT2A (0.50) MAPTMAPK1NOTUMNPY5RKDM4E
SCHEMBL21590255 0.81 NPY5R (0.46) NPY5RKMT2AHRH3
SCHEMBL22837853 0.81 LTA4H (0.41) MAPTALDH1A1GFERKDM4EKMT2A
SCHEMBL8728952 0.81 L3MBTL3 (0.40) MAPTALDH1A1GFERKDM4EKMT2A
SCHEMBL5537153 0.81 ME3 (0.52) MAPTLMNAALDH1A1TDP1KDM4E
SCHEMBL5537144 0.81 MCHR1 (0.42) MAPTALDH1A1GFERNPY5RKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
EP-1228367-B1 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF ASUBIO PHARMA CO LTD (JP) 2007-09-26 EP disclosed
US-20060178401-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof DAIICHI ASUBIO PHARMA CO., LTD. 2006-08-10 US disclosed
CN-1264821-C Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof SUNTORY LTD (JP) 2006-07-19 CN disclosed
CN-1449493-A Aminophenoxyacetamide derivatives and pharmaceutical compositions containing them SUNTORY LTD (JP) 2003-10-15 CN disclosed
US-20030139447-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof ASUBIO PHARMA CO., LTD. (JP) 2003-07-24 US disclosed
EP-1228367-A2 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF SUNTORY LIMITED (JP) 2002-08-07 EP disclosed
WO-2001079170-A2 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF SUNTORY LIMITED (JP) 2001-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139447-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof SCN10A, CAMK2A, CAMK2B MAPT 1414/4885LMNA 3529/4885ALDH1A1 3310/4885
US-20060178401-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof NR0B1, NR0B2, NR4A1 MAPT 2571/4885LMNA 4085/4885ALDH1A1 1322/4885
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 MAPT 3149/4885LMNA 1463/4885ALDH1A1 1267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.